Greenwich, CT, United States of America

David Sackler

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Euro-Celtique S.a.. Active years: 1998-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Sackler. Retrieved from https://idiyas.com/inventor/david-sackler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 441(Granted Patents)


Company Filing History:


Years Active: 1998-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of David Sackler

Introduction

David Sackler is an accomplished inventor based in Greenwich, CT (US). He has made significant contributions to the field of opioid formulations, focusing on bioavailable sustained release oral opioid analgesic dosage forms. With a total of 3 patents to his name, Sackler's work is pivotal in advancing pain management therapies.

Latest Patents

Sackler's latest patents include innovative melt-extruded orally administrable opioid formulations. These formulations comprise a plurality of multiparticulates produced via melt extrusion techniques. His work aims to enhance the bioavailability and sustained release of opioid analgesics, providing more effective pain relief options for patients.

Career Highlights

Throughout his career, Sackler has been associated with Euro-Celtique S.A., a company known for its focus on pharmaceutical innovations. His expertise in opioid formulations has positioned him as a key player in the development of advanced pain management solutions.

Collaborations

Sackler has collaborated with notable professionals in the field, including Benjamin Oshlack and Mark Chasin. These partnerships have contributed to the successful development of his patented formulations.

Conclusion

David Sackler's contributions to opioid formulations reflect his commitment to improving patient care through innovative solutions. His work continues to influence the pharmaceutical industry and enhance pain management therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…